ARCHIVES

Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies

This article is from The Cancer Letter archive.

Vol. 36 No. 24 | June 25, 2010

Download PDF Visit The Full Archive

Related Articles

New Biologic Modalities Show Promise In Treatment Of Lymphomas, Research Finds

June 28, 2002

Hugh Creech, Fox Chase Chemotherapy Pioneer, Dead at 92

January 31, 2003

NCI Outlines Plan for Marin County Breast Cancer Review

November 22, 2002

Overdiagnosis Can Result In Harm To Patients, Experts Say.

November 3, 2006

FDA claims news coverage violated privacy of applicants for oncology job.

March 4, 2005

In Brief: NCAB Still Without New Appinees As Carter, Califano Delay Drags On; Keele to U. Kansas

January 19, 1979